Lombardia Capital Partners’s Pacira BioSciences PCRX Stock Holding History

Lombardia Capital Partners’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-13,927	Closed	-$738K	–	213
2016 Q1	$738K	Buy	13,927 +7,998	+135%	+$468K	0.04%	165
2015 Q4	$455K	Sell	5,929 -3,881	-40%	-$220K	0.02%	168
2015 Q3	$403K	Buy	+9,810	New	+$601K	0.02%	169

Other funds holding PCRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Lombardia Capital Partners's PCRX Position: Q2 2016 in Review

Lombardia Capital Partners sold out of Pacira BioSciences (PCRX) in Q2 2016, closing a stake of 13,927 shares — an estimated $738K sold.

Lombardia Capital Partners first reported a position in PCRX in Q3 2015 and held it in 3 quarters. The position peaked at $738K in Q1 2016. 183 funds tracked by Wall St. Rank hold PCRX as of Q2 2016.

Lombardia Capital Partners reported no remaining Pacira BioSciences position as of Q2 2016 after selling out during the quarter.
Lombardia Capital Partners sold 13,927 Pacira BioSciences shares in Q2 2016, an estimated $738K.
Lombardia Capital Partners first reported a position in Pacira BioSciences in Q3 2015 and held it in 3 quarters.
Lombardia Capital Partners's Pacira BioSciences position peaked at $738K in Q1 2016.
183 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2016.

Based on Lombardia Capital Partners's 13F filing for Q2 2016, filed 4 Aug 2016.